Stroke Diagnostics and Therapeutics - Global Market Outlook (2017-2026)
According to Stratistics MRC, the Global Stroke Diagnostics and Therapeutics market is accounted for $23,849.39 Million in 2017 and is expected to reach $49,698.68 Million by 2026 growing at a CAGR of 8.5% during the forecast period. Factors such as technological advancement, growing aging population, and people suffering from diabetes are favouring the market. On the other hand, increasing health expenditure, hypertension and also increasing tobacco users are also fuelling the market. However factors such as unfavourable reimbursement scenario and high cost of treatments are hampering the market growth. Stroke is referred to brain attack occurs when there is a holdup in the supply of blood to the brain which leads brain cells to die.
Depending upon Application, Haemorrhagic Stroke is caused on account of the arteries in the brain either leaking blood or bursting open. When it happens, blood collects in the brain tissue. This is toxic for the brain tissue causing the cells in that area to weaken and die. It is one among the cause of death and a leading cause of serious, long-term disability across the world.
By Geography, stroke diagnostics and therapeutics market in Asia is expected to witness the high growth rate in and expected to remain top among other regions in the forecast period due to growing aging population, evolving R&D activities for drug discovery and development, increasing government support in the form of funding and developing healthcare infrastructure in the region. In addition, growing demographics and economies in the developing countries such as India, China, and Japan are expected to lead the growth in the stroke diagnostics and therapeutics market in Asia.
Some of the key players diagnostics and therapeutics market include are Siemens AG, GE Healthcare, Medtronic plc, Bayer AG, Abbott Laboratories, Cordis Corporation, Boston Scientific Corporation, Genentech, Inc., Koninklijke Philips N.V., Stryker Corporation, Merck & Co., Inc, B. Braun Melsungen AG, Teleflex Inc., Cardinal Health, Merck Sharp & Dohme Corp., GlaxoSmithKline plc, Bristol-Myers Squibb., Boehringer Ingelheim, Johnson & Johnson and Daiichi Sankyo.
Types Covered:
Depending upon Application, Haemorrhagic Stroke is caused on account of the arteries in the brain either leaking blood or bursting open. When it happens, blood collects in the brain tissue. This is toxic for the brain tissue causing the cells in that area to weaken and die. It is one among the cause of death and a leading cause of serious, long-term disability across the world.
By Geography, stroke diagnostics and therapeutics market in Asia is expected to witness the high growth rate in and expected to remain top among other regions in the forecast period due to growing aging population, evolving R&D activities for drug discovery and development, increasing government support in the form of funding and developing healthcare infrastructure in the region. In addition, growing demographics and economies in the developing countries such as India, China, and Japan are expected to lead the growth in the stroke diagnostics and therapeutics market in Asia.
Some of the key players diagnostics and therapeutics market include are Siemens AG, GE Healthcare, Medtronic plc, Bayer AG, Abbott Laboratories, Cordis Corporation, Boston Scientific Corporation, Genentech, Inc., Koninklijke Philips N.V., Stryker Corporation, Merck & Co., Inc, B. Braun Melsungen AG, Teleflex Inc., Cardinal Health, Merck Sharp & Dohme Corp., GlaxoSmithKline plc, Bristol-Myers Squibb., Boehringer Ingelheim, Johnson & Johnson and Daiichi Sankyo.
Types Covered:
- Diagnostics
- Therapeutics
- Haemorrhagic Stroke
- Ischemic Stroke
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
1 EXECUTIVE SUMMARY
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Emerging Markets
3.8 Futuristic Market Scenario
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL STROKE DIAGNOSTICS AND THERAPEUTICS MARKET, BY TYPE
5.1 Introduction
5.2 Diagnostics
5.2.1 Magnetic Resonance Imaging (MRI)
5.2.2 Computed Tomography Scan (CT scan)
5.2.3 Electrocardiography
5.2.4 Carotid Ultrasound
5.2.5 Cerebral Angiography
5.2.6 Other Diagnostics
5.3 Therapeutics
5.3.1 Tissue Plasminogen Activator
5.3.2 Antiplatelet
5.3.3 Antihypertensive
5.3.4 Anticoagulant
6 GLOBAL STROKE DIAGNOSTICS AND THERAPEUTICS MARKET, BY APPLICATION
6.1 Introduction
6.2 Haemorrhagic Stroke
6.3 Ischemic Stroke
7 GLOBAL STROKE DIAGNOSTICS AND THERAPEUTICS MARKET, BY GEOGRAPHY
7.1 Introduction
7.2 North America
7.2.1 US
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 Italy
7.3.4 France
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 New Zealand
7.4.6 South Korea
7.4.7 Rest of Asia Pacific
7.5 South America
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 UAE
7.6.3 Qatar
7.6.4 South Africa
7.6.5 Rest of Middle East & Africa
8 KEY DEVELOPMENTS
8.1 Acquisitions & Mergers
8.2 Agreements, Partnerships, Collaborations and Joint Ventures
8.3 Product Launch & Expansions
8.4 Other Activities
9 COMPANY PROFILING
9.1 Siemens AG
9.2 GE Healthcare
9.3 Medtronic plc
9.4 Bayer AG
9.5 Abbott Laboratories
9.6 Cordis Corporation
9.7 Boston Scientific Corporation
9.8 Genentech, Inc.
9.9 Koninklijke Philips N.V.
9.10 Stryker Corporation
9.11 Merck & Co., Inc
9.12 B. Braun Melsungen AG
9.13 Teleflex Inc.
9.14 Cardinal Health
9.15 Merck Sharp & Dohme Corp.
9.16 GlaxoSmithKline plc
9.17 Bristol-Myers Squibb.
9.18 Boehringer Ingelheim
9.19 Johnson & Johnson
9.20 Daiichi Sankyo
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Emerging Markets
3.8 Futuristic Market Scenario
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL STROKE DIAGNOSTICS AND THERAPEUTICS MARKET, BY TYPE
5.1 Introduction
5.2 Diagnostics
5.2.1 Magnetic Resonance Imaging (MRI)
5.2.2 Computed Tomography Scan (CT scan)
5.2.3 Electrocardiography
5.2.4 Carotid Ultrasound
5.2.5 Cerebral Angiography
5.2.6 Other Diagnostics
5.3 Therapeutics
5.3.1 Tissue Plasminogen Activator
5.3.2 Antiplatelet
5.3.3 Antihypertensive
5.3.4 Anticoagulant
6 GLOBAL STROKE DIAGNOSTICS AND THERAPEUTICS MARKET, BY APPLICATION
6.1 Introduction
6.2 Haemorrhagic Stroke
6.3 Ischemic Stroke
7 GLOBAL STROKE DIAGNOSTICS AND THERAPEUTICS MARKET, BY GEOGRAPHY
7.1 Introduction
7.2 North America
7.2.1 US
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 Italy
7.3.4 France
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 New Zealand
7.4.6 South Korea
7.4.7 Rest of Asia Pacific
7.5 South America
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 UAE
7.6.3 Qatar
7.6.4 South Africa
7.6.5 Rest of Middle East & Africa
8 KEY DEVELOPMENTS
8.1 Acquisitions & Mergers
8.2 Agreements, Partnerships, Collaborations and Joint Ventures
8.3 Product Launch & Expansions
8.4 Other Activities
9 COMPANY PROFILING
9.1 Siemens AG
9.2 GE Healthcare
9.3 Medtronic plc
9.4 Bayer AG
9.5 Abbott Laboratories
9.6 Cordis Corporation
9.7 Boston Scientific Corporation
9.8 Genentech, Inc.
9.9 Koninklijke Philips N.V.
9.10 Stryker Corporation
9.11 Merck & Co., Inc
9.12 B. Braun Melsungen AG
9.13 Teleflex Inc.
9.14 Cardinal Health
9.15 Merck Sharp & Dohme Corp.
9.16 GlaxoSmithKline plc
9.17 Bristol-Myers Squibb.
9.18 Boehringer Ingelheim
9.19 Johnson & Johnson
9.20 Daiichi Sankyo
LIST OF TABLES
Table 1 Global Stroke Diagnostics and Therapeutics Market Outlook, By Region (2016-2026) ($MN)
Table 2 Global Stroke Diagnostics and Therapeutics Market Outlook, By Type (2016-2026) ($MN)
Table 3 Global Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2016-2026) ($MN)
Table 4 Global Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2016-2026) ($MN)
Table 5 Global Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2016-2026) ($MN)
Table 6 Global Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2016-2026) ($MN)
Table 7 Global Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2016-2026) ($MN)
Table 8 Global Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2016-2026) ($MN)
Table 9 Global Stroke Diagnostics and Therapeutics Market Outlook, By Others (2016-2026) ($MN)
Table 10 Global Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2016-2026) ($MN)
Table 11 Global Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2016-2026) ($MN)
Table 12 Global Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2016-2026) ($MN)
Table 13 Global Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2016-2026) ($MN)
Table 14 Global Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2016-2026) ($MN)
Table 15 Global Stroke Diagnostics and Therapeutics Market Outlook, By Application (2016-2026) ($MN)
Table 16 Global Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
Table 17 Global Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2016-2026) ($MN)
Table 18 North America Stroke Diagnostics and Therapeutics Market Outlook, By Type (2016-2026) ($MN)
Table 19 North America Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2016-2026) ($MN)
Table 20 North America Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2016-2026) ($MN)
Table 21 North America Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2016-2026) ($MN)
Table 22 North America Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2016-2026) ($MN)
Table 23 North America Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2016-2026) ($MN)
Table 24 North America Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2016-2026) ($MN)
Table 25 North America Stroke Diagnostics and Therapeutics Market Outlook, By Others (2016-2026) ($MN)
Table 26 North America Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2016-2026) ($MN)
Table 27 North America Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2016-2026) ($MN)
Table 28 North America Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2016-2026) ($MN)
Table 29 North America Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2016-2026) ($MN)
Table 30 North America Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2016-2026) ($MN)
Table 31 North America Stroke Diagnostics and Therapeutics Market Outlook, By Application (2016-2026) ($MN)
Table 32 North America Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
Table 33 North America Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2016-2026) ($MN)
Table 34 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Type (2016-2026) ($MN)
Table 35 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2016-2026) ($MN)
Table 36 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2016-2026) ($MN)
Table 37 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2016-2026) ($MN)
Table 38 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2016-2026) ($MN)
Table 39 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2016-2026) ($MN)
Table 40 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2016-2026) ($MN)
Table 41 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Others (2016-2026) ($MN)
Table 42 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2016-2026) ($MN)
Table 43 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2016-2026) ($MN)
Table 44 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2016-2026) ($MN)
Table 45 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2016-2026) ($MN)
Table 46 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2016-2026) ($MN)
Table 47 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Application (2016-2026) ($MN)
Table 48 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
Table 49 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2016-2026) ($MN)
Table 50 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Type (2016-2026) ($MN)
Table 51 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2016-2026) ($MN)
Table 52 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2016-2026) ($MN)
Table 53 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2016-2026) ($MN)
Table 54 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2016-2026) ($MN)
Table 55 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2016-2026) ($MN)
Table 56 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2016-2026) ($MN)
Table 57 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Others (2016-2026) ($MN)
Table 58 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2016-2026) ($MN)
Table 59 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2016-2026) ($MN)
Table 60 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2016-2026) ($MN)
Table 61 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2016-2026) ($MN)
Table 62 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2016-2026) ($MN)
Table 63 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Application (2016-2026) ($MN)
Table 64 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
Table 65 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2016-2026) ($MN)
Table 66 South America Stroke Diagnostics and Therapeutics Market Outlook, By Type (2016-2026) ($MN)
Table 67 South America Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2016-2026) ($MN)
Table 68 South America Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2016-2026) ($MN)
Table 69 South America Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2016-2026) ($MN)
Table 70 South America Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2016-2026) ($MN)
Table 71 South America Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2016-2026) ($MN)
Table 72 South America Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2016-2026) ($MN)
Table 73 South America Stroke Diagnostics and Therapeutics Market Outlook, By Others (2016-2026) ($MN)
Table 74 South America Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2016-2026) ($MN)
Table 75 South America Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2016-2026) ($MN)
Table 76 South America Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2016-2026) ($MN)
Table 77 South America Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2016-2026) ($MN)
Table 78 South America Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2016-2026) ($MN)
Table 79 South America Stroke Diagnostics and Therapeutics Market Outlook, By Application (2016-2026) ($MN)
Table 80 South America Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
Table 81 South America Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2016-2026) ($MN)
Table 82 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Type (2016-2026) ($MN)
Table 83 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2016-2026) ($MN)
Table 84 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2016-2026) ($MN)
Table 85 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2016-2026) ($MN)
Table 86 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2016-2026) ($MN)
Table 87 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2016-2026) ($MN)
Table 88 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2016-2026) ($MN)
Table 89 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Others (2016-2026) ($MN)
Table 90 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2016-2026) ($MN)
Table 91 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2016-2026) ($MN)
Table 92 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2016-2026) ($MN)
Table 93 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2016-2026) ($MN)
Table 94 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2016-2026) ($MN)
Table 95 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Application (2016-2026) ($MN)
Table 96 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
Table 97 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2016-2026) ($MN)
Table 1 Global Stroke Diagnostics and Therapeutics Market Outlook, By Region (2016-2026) ($MN)
Table 2 Global Stroke Diagnostics and Therapeutics Market Outlook, By Type (2016-2026) ($MN)
Table 3 Global Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2016-2026) ($MN)
Table 4 Global Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2016-2026) ($MN)
Table 5 Global Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2016-2026) ($MN)
Table 6 Global Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2016-2026) ($MN)
Table 7 Global Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2016-2026) ($MN)
Table 8 Global Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2016-2026) ($MN)
Table 9 Global Stroke Diagnostics and Therapeutics Market Outlook, By Others (2016-2026) ($MN)
Table 10 Global Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2016-2026) ($MN)
Table 11 Global Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2016-2026) ($MN)
Table 12 Global Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2016-2026) ($MN)
Table 13 Global Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2016-2026) ($MN)
Table 14 Global Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2016-2026) ($MN)
Table 15 Global Stroke Diagnostics and Therapeutics Market Outlook, By Application (2016-2026) ($MN)
Table 16 Global Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
Table 17 Global Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2016-2026) ($MN)
Table 18 North America Stroke Diagnostics and Therapeutics Market Outlook, By Type (2016-2026) ($MN)
Table 19 North America Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2016-2026) ($MN)
Table 20 North America Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2016-2026) ($MN)
Table 21 North America Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2016-2026) ($MN)
Table 22 North America Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2016-2026) ($MN)
Table 23 North America Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2016-2026) ($MN)
Table 24 North America Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2016-2026) ($MN)
Table 25 North America Stroke Diagnostics and Therapeutics Market Outlook, By Others (2016-2026) ($MN)
Table 26 North America Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2016-2026) ($MN)
Table 27 North America Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2016-2026) ($MN)
Table 28 North America Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2016-2026) ($MN)
Table 29 North America Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2016-2026) ($MN)
Table 30 North America Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2016-2026) ($MN)
Table 31 North America Stroke Diagnostics and Therapeutics Market Outlook, By Application (2016-2026) ($MN)
Table 32 North America Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
Table 33 North America Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2016-2026) ($MN)
Table 34 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Type (2016-2026) ($MN)
Table 35 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2016-2026) ($MN)
Table 36 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2016-2026) ($MN)
Table 37 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2016-2026) ($MN)
Table 38 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2016-2026) ($MN)
Table 39 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2016-2026) ($MN)
Table 40 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2016-2026) ($MN)
Table 41 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Others (2016-2026) ($MN)
Table 42 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2016-2026) ($MN)
Table 43 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2016-2026) ($MN)
Table 44 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2016-2026) ($MN)
Table 45 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2016-2026) ($MN)
Table 46 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2016-2026) ($MN)
Table 47 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Application (2016-2026) ($MN)
Table 48 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
Table 49 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2016-2026) ($MN)
Table 50 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Type (2016-2026) ($MN)
Table 51 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2016-2026) ($MN)
Table 52 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2016-2026) ($MN)
Table 53 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2016-2026) ($MN)
Table 54 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2016-2026) ($MN)
Table 55 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2016-2026) ($MN)
Table 56 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2016-2026) ($MN)
Table 57 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Others (2016-2026) ($MN)
Table 58 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2016-2026) ($MN)
Table 59 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2016-2026) ($MN)
Table 60 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2016-2026) ($MN)
Table 61 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2016-2026) ($MN)
Table 62 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2016-2026) ($MN)
Table 63 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Application (2016-2026) ($MN)
Table 64 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
Table 65 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2016-2026) ($MN)
Table 66 South America Stroke Diagnostics and Therapeutics Market Outlook, By Type (2016-2026) ($MN)
Table 67 South America Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2016-2026) ($MN)
Table 68 South America Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2016-2026) ($MN)
Table 69 South America Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2016-2026) ($MN)
Table 70 South America Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2016-2026) ($MN)
Table 71 South America Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2016-2026) ($MN)
Table 72 South America Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2016-2026) ($MN)
Table 73 South America Stroke Diagnostics and Therapeutics Market Outlook, By Others (2016-2026) ($MN)
Table 74 South America Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2016-2026) ($MN)
Table 75 South America Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2016-2026) ($MN)
Table 76 South America Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2016-2026) ($MN)
Table 77 South America Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2016-2026) ($MN)
Table 78 South America Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2016-2026) ($MN)
Table 79 South America Stroke Diagnostics and Therapeutics Market Outlook, By Application (2016-2026) ($MN)
Table 80 South America Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
Table 81 South America Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2016-2026) ($MN)
Table 82 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Type (2016-2026) ($MN)
Table 83 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2016-2026) ($MN)
Table 84 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2016-2026) ($MN)
Table 85 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2016-2026) ($MN)
Table 86 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2016-2026) ($MN)
Table 87 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2016-2026) ($MN)
Table 88 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2016-2026) ($MN)
Table 89 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Others (2016-2026) ($MN)
Table 90 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2016-2026) ($MN)
Table 91 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2016-2026) ($MN)
Table 92 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2016-2026) ($MN)
Table 93 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2016-2026) ($MN)
Table 94 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2016-2026) ($MN)
Table 95 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Application (2016-2026) ($MN)
Table 96 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
Table 97 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2016-2026) ($MN)
